Page last updated: 2024-10-23

bisbenzimidazole and Hypoxia-Ischemia, Brain

bisbenzimidazole has been researched along with Hypoxia-Ischemia, Brain in 2 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Hypoxia-Ischemia, Brain: A disorder characterized by a reduction of oxygen in the blood combined with reduced blood flow (ISCHEMIA) to the brain from a localized obstruction of a cerebral artery or from systemic hypoperfusion. Prolonged hypoxia-ischemia is associated with ISCHEMIC ATTACK, TRANSIENT; BRAIN INFARCTION; BRAIN EDEMA; COMA; and other conditions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Unal Cevik, I1
Dalkara, T1
Sheng, WW1
Li, CT1
Zhang, WP1
Yuan, YM1
Hu, H1
Fang, SH1
Zhang, L1
Wei, EQ1

Other Studies

2 other studies available for bisbenzimidazole and Hypoxia-Ischemia, Brain

ArticleYear
Intravenously administered propidium iodide labels necrotic cells in the intact mouse brain after injury.
    Cell death and differentiation, 2003, Volume: 10, Issue:8

    Topics: Animals; Apoptosis; Biomarkers; Bisbenzimidazole; Brain; Brain Injuries; Cell Death; Hypoxia-Ischemi

2003
Distinct roles of CysLT1 and CysLT2 receptors in oxygen glucose deprivation-induced PC12 cell death.
    Biochemical and biophysical research communications, 2006, Jul-21, Volume: 346, Issue:1

    Topics: Acetates; Animals; Bisbenzimidazole; Cell Death; Cyclopropanes; Flow Cytometry; Glucose; Hypoxia-Isc

2006